Endocrinology
Trilostane for Dogs With Hyperadrenocorticism
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
Menu
DVM, MS, DACVIM
Dr. Archer is associate professor and service chief in the Department of Clinical Sciences at Mississippi State University College of Veterinary Medicine, where he received his DVM degree and completed an internship and residency. His research focuses on hematology and immune-mediated disorders, especially use of immunosuppressive therapy.
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
Stay current with the latest techniques and information – sign up below to start your FREE Today’s Veterinary Practice subscription today.
Start My Subscription